Discusses what is unique about the company and what newsflow investors can expect - Michel Baijot, CEO of Asit Biotech 00:00:00
In this interview Michel Baijot, CEO of Asit Biotech, discusses what is unique about the company and what newsflow investors can expect from ASIT in the second half of 2019.